levetiracetam and Liver-Failure

levetiracetam has been researched along with Liver-Failure* in 1 studies

Other Studies

1 other study(ies) available for levetiracetam and Liver-Failure

ArticleYear
Levetiracetam following liver and kidney failure in late-onset anticonvulsant hypersensitivity syndrome.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2014, Volume: 21, Issue:5

    Anticonvulsant hypersensitivity syndrome is an adverse drug reaction usually occurring from 1 to 8 weeks after exposure to antiepileptic drugs. It can threaten life by affecting the liver, kidneys, central nervous system or lungs. We present a 47-year-old patient treated with phenytoin, lamotrigine and clobazam for 7 years. He presented with hepatic and renal failure in relation to this syndrome demonstrated by renal biopsy. Prognosis was excellent due to an early diagnosis leading to cessation of the causative agents. Levetiracetam was started with a good response.

    Topics: Anticonvulsants; Drug Hypersensitivity Syndrome; Epilepsy; Humans; Levetiracetam; Liver Failure; Male; Middle Aged; Piracetam; Renal Insufficiency

2014